GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 44.30
+2.32 (5.53%)
At close: Jul 20, 2025
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 3.69 billion as of July 22, 2025. Its market cap has increased by 60.24% in one year.
Market Cap
3.69B
Enterprise Value
3.54B
Revenue
3.27B
Ranking
n/a
PE Ratio
15.22
Stock Price
44.30
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.69B, an increase of 547.20%. That is a compound annual growth rate of 9.83%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Commercial International Bank Egypt (CIB) S.A.E. | 273.82B |
| El Sewedy Electric Company | 165.91B |
| Suez Canal Company for Technology Settling (S.A.E) | 135.56B |
| Talaat Moustafa Group Holding | 113.36B |
| Eastern Company S.A.E | 97.50B |
| Misr Fertilizer Production Company | 81.09B |
| Egypt Aluminum | 73.01B |
| Alexandria Container&Cargo Handling Company | 68.74B |